Re­plac­ing lab rats? Bay Area tech fund backs Em­u­late's $36M round to com­mer­cial­ize 'or­gan chip' tech

Af­ter ink­ing a slew of big phar­ma part­ner­ships ear­li­er this year, Em­u­late is stack­ing away $36 mil­lion in new cap­i­tal to com­mer­cial­ize a drug-test­ing tech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER